Trial intelligence / Profile preview

Docetaxel vs Cisplatin with Radiotherapy in NPC

NCT03177174Phase 2Completed

Start
Jun 2017
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of docetaxel in nasopharyngeal carcinoma (NPC). Started Jun 2017; status: completed.

02

Drugs

docetaxel
03

Conditions

nasopharyngeal carcinoma (NPC)

Beyond the preview

Go deeper on NCT03177174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03177174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call